Recent Patents on Anti-Cancer Drug Discovery

Papers
(The TQCC of Recent Patents on Anti-Cancer Drug Discovery is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Developments in the Application of 1,2,3-Triazoles in Cancer Treatment39
Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019)21
Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment16
Reposition of the Fungicide Ciclopirox for Cancer Treatment16
Cancer Immunotherapy - Immune Checkpoint Inhibitors in Hepatocellular Carcinoma16
Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review15
Application of Nano Drug Delivery System (NDDS) in Cancer Therapy: A Perspective14
Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin14
Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer13
Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 112
Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years11
Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer11
Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies11
Feasibility of Repurposing Clioquinol for Cancer Therapy11
Bortezomib – First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature11
Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival10
Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity after Bee Venom Treatment10
In Vitro and In Vivo Evaluation of Novel DTX-Loaded Multifunctional Heparin-Based Polymeric Micelles Targeting Folate Receptors and Endosomes10
The Patent Landscape of BRAF Target and KRAS Target9
LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA39
Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials9
The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment8
Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer8
Recent Trend for EGFR-Based and ALK-Based Targets: A Patent Analysis8
Immunological Mechanism and Clinical Application of PAMP Adjuvants8
The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX8
Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review8
Artificial Intelligence and Cancer Drug Development8
N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer8
Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells7
Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment7
Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy7
Recent Patents on Anti-Cancer Potential of Helenalin7
Research and Patents Status of Selected Phytochemicals Against Cancer: How Close and How Far?7
Expression of B Cell Translocation Gene 1 Protein in Colon Carcinoma and its Clinical Significance7
Imitating Hypoxia and Tumor Microenvironment with Immune Evasion by Employing Three Dimensional In vitro Cellular Models: Impressive Tool in Drug Discovery7
Natural Product as Substrates of ABC Transporters: A Review7
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer7
Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells6
Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-based Role in Disease Management6
Novel Pathways and Mechanisms of Nicotine-Induced Oral Carcinogenesis6
Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years6
Transdermal Drug Delivery: A Step towards Treatment of Cancer6
The Synthesis, Structural Modification and Mode of Anticancer Action of Evodiamine: A Review6
Terpenes with Antitumor Activity: A Patent Review5
Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer5
Overview of Inorganic Nanoparticles: An Expanding Horizon in Tumor Therapeutics5
Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours5
The Impact of Polyphenolics in the Management of Breast Cancer: Mechanistic Aspects and Recent Patents5
Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer5
Antioxidant, Anti-Inflammatory and Anticancer Activities of the Methanolic Extract of Thottea siliquosa: An In Vitro and In Silico Study5
Daidzein and Chicory Extract Arrest the Cell Cycle via Inhibition of Cyclin D/CDK4 and Cyclin A/CDK2 Gene Expression in Hepatocellular Carcinoma5
STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells5
Modulation of MicroRNAs by Euphorbia Microsciadia Boiss in MDA-MB-231 Cell Line: New Possibilities in Breast Cancer Therapy5
An Update of Lysine Specific Demethylase 1 Inhibitor: A Patent Review (2016-2020)5
Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review5
Cancer Stem Cells and their Management in Cancer Therapy4
Eudragit, a Nifty Polymer for Anticancer Preparations: A Patent Review4
Lentiviral-Mediated Beclin-1 Overexpression Inhibits Cell Proliferation and Induces Autophagy of Human Esophageal Carcinoma Eca109 Cell Xenograft in Nude Mice4
Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification4
A Link Between Chemical Structure and Biological Activity in Triterpenoids4
Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response4
pH-responsive Sulfated Hyaluronic Acid Nanoparticles Targeting Tumor Cells and CAFs for the Treatment of Breast Cancer4
Qigefang Inhibits Migration, Invasion, and Metastasis of ESCC by Inhibiting Gas6/Axl Signaling Pathway4
Recent Patents on the Development of c-Met Kinase Inhibitors4
Recent Progress in Natural Anticancer Agents Discovery from Tea (Camellia sinensis): A Review4
Metallodrugs as Anticancer Chemotherapeutics and Diagnostic Agents: A Critical Patent Review (2010-2020)4
Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway4
SOX4 Serves an Oncogenic Role in the Tumourigenesis of Human Breast Adenocarcinoma by Promoting Cell Proliferation, Migration and Inhibiting Apoptosis4
MiR-125b Inhibits Cell Proliferation and Induces Apoptosis in Human Colon Cancer SW480 Cells via Targeting STAT34
Combining PD-1 Inhibitor with VEGF/VEGFR2 Inhibitor in Chemotherapy: Report of a Patient with End-Stage Cholangiocarcinoma and Review of Literature4
Exploring the Anticancer Potentials of Polyphenols: A Comprehensive Review of Patents in the Last Five Years4
ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways4
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy4
0.022039175033569